Golden State Medical Supply Inc., Camarillo, California, has been awarded a maximum $10,306,354 modification (P00006) exercising the third one-year option period of a one-year base contract (SPE2D2-20-D-0098) with four one-year option periods for duloxetine hydrochloride delayed release capsules. This is a fixed-price, requirements contract. Location of performance is Spain, with a Sept. 16, 2024, performance completion date. Using customers are Army, Navy, Air Force, Marine Corps, Coast Guard, Department of Veterans Affairs, Indian Health Services, and Federal Bureau of Prisons. Type of appropriation is fiscal 2023 through 2024 defense working capital funds. The contracting agency is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania.
Recommended
free preview